These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1604797)

  • 1. The intestinal and serum humoral immune response of mice to orally administered antigens in liposomes: II. The response to liposome-entrapped bacterial proteins.
    Clarke CJ; Stokes CR
    Vet Immunol Immunopathol; 1992 Apr; 32(1-2):139-48. PubMed ID: 1604797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intestinal and serum humoral immune response of mice to systemically and orally administered antigens in liposomes: I. The response to liposome-entrapped soluble proteins.
    Clarke CJ; Stokes CR
    Vet Immunol Immunopathol; 1992 Apr; 32(1-2):125-38. PubMed ID: 1604795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
    Harokopakis E; Hajishengallis G; Michalek SM
    Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
    Elson CO; Ealding W
    J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of intestinal IgA and IgG antibodies preventing adhesion of verotoxin-producing Escherichia coli to Caco-2 cells by oral immunization with liposomes.
    Tana ; Watarai S; Isogai E; Oguma K
    Lett Appl Microbiol; 2003; 36(3):135-9. PubMed ID: 12581370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens.
    Harokopakis E; Childers NK; Michalek SM; Zhang SS; Tomasi M
    J Immunol Methods; 1995 Sep; 185(1):31-42. PubMed ID: 7665899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
    Shimauchi H
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin.
    Bourguin I; Chardes T; Mevelec MN; Woodman JP; Bout D
    FEMS Microbiol Lett; 1991 Jul; 65(3):265-71. PubMed ID: 1916225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
    Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
    Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses of mice to orally administered asialo GM1-specific rabbit IgG in the presence or absence of cholera toxin.
    Umesaki Y; Setoyama H
    Immunology; 1992 Feb; 75(2):386-8. PubMed ID: 1551702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of a bacterial immunomodulator enhances the immune response to cholera toxin.
    Fló J; Goldman H; Roux ME; Massouh E
    Vaccine; 1996 Aug; 14(12):1167-73. PubMed ID: 8911015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome-entrapped antigen.
    Irie T; Watarai S; Kodama H
    Dev Comp Immunol; 2003 May; 27(5):413-21. PubMed ID: 12631523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
    Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
    Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization.
    VanCott JL; Kobayashi T; Yamamoto M; Pillai S; McGhee JR; Kiyono H
    Vaccine; 1996 Apr; 14(5):392-8. PubMed ID: 8735550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG DNA, liposome and refined antigen oral cholera vaccine.
    Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers.
    Chaicumpa W; Chongsa-nguan M; Kalambaheti T; Wilairatana P; Srimanote P; Makakunkijcharoen Y; Looareesuwan S; Sakolvaree Y
    Vaccine; 1998 Apr; 16(7):678-84. PubMed ID: 9562686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
    Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
    Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.